Novel loss‑of‑function mutation in BRCA2 gene identified in a Chinese female with a family history of ovarian cancer: A case report

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tielent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI

Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI

Chen S and Parmigiani G: Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 25:1329–1333. 2007. View Article : Google Scholar : PubMed/NCBI

Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E, Evans DG, Izatt L, Eeles RA, Adlard J, et al: Cancer risks for BRCA1 and BRCA2 mutation carriers: Results from prospective analysis of EMBRACE. J Natl Cancer Inst. 105:812–822. 2013. View Article : Google Scholar : PubMed/NCBI

Claus EB, Risch N and Thompson WD: Autosomal dominant inheritance of earlyonset breast cancer. Implications for risk prediction. Cancer. 73:643–651. 1994. View Article : Google Scholar : PubMed/NCBI

Petrucelli N, Daly MB and Pal T: BRCA1-and BRCA2-associated hereditary breast and ovarian cancer. Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K and Amemiya A: University of Washington; Seattle: 2016

Narod SA and Foulkes WD: BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer. 4:665–676. 2004. View Article : Google Scholar : PubMed/NCBI

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al: Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 17:405–424. 2015. View Article : Google Scholar : PubMed/NCBI

Song H, Cicek MS, Dicks E, Harrington P, Ramus SJ, Cunningham JM, Fridley BL, Tyrer JP, Alsop J, et al: The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population. Hum Mol Genet. 23:4703–4709. 2014. View Article : Google Scholar : PubMed/NCBI

Kim YC, Zhao L, Zhang H, Huang Y, Cui J, Xiao F, Downs B and Wang SM: Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients. Oncotarget. 7:9600–9612. 2016.PubMed/NCBI

Lifton RP: Individual genomes on the horizon. N Engl J Med. 362:1235–1236. 2010. View Article : Google Scholar : PubMed/NCBI

Goossens D, Moens LN, Nelis E, Lenaerts AS, Glassee W, Kalbe A, Frey B, Kopal G, De Jonghe P, De Rijk P and Del-Favero J: Simultaneous mutation and copy number variation (CNV) detection by multiplex PCR-based GS-FLX sequencing. Hum Mutat. 30:472–476. 2009. View Article : Google Scholar : PubMed/NCBI

Daiger SP, Sullivan LS, Bowne SJ, Birch DG, Heckenlively JR, Pierce EA and Weinstock GM: Targeted high-throughput DNA sequencing for gene discovery in retinitis pigmentosa. Adv Exp Med Biol. 664:325–331. 2010. View Article : Google Scholar : PubMed/NCBI

Hoischen A, Gilissen C, Arts P, Wieskamp N, van der Vliet W, Vermeer S, Steehouwer M, de Vries P, Meijer R, Seiqueros J, et al: Massively parallel sequencing of ataxia genes after array-based enrichment. Hum Mutat. 31:494–499. 2010. View Article : Google Scholar : PubMed/NCBI

Chou LS, Liu CS, Boese B, Zhang X and Mao R: DNA sequence capture and enrichment by microarray followed by next-generation sequencing for targeted resequencing: Neurofibromatosis type 1 gene as a model. Clin Chem. 56:62–72. 2010. View Article : Google Scholar : PubMed/NCBI

Mamanova L, Coffey AJ, Scott CE, Kozarewa I, Turner EH, Kumar A, Howard E, Shendure J and Turner DJ: Target-enrichment strategies for next-generation sequencing. Nat Methods. 7:111–118. 2010. View Article : Google Scholar : PubMed/NCBI

Teo SM, Pawitan Y, Ku CS, Chia KS and Salim A: Statistical challenges associated with detecting copy number variations with next-generation sequencing. Bioinformatics. 28:2711–2718. 2012. View Article : Google Scholar : PubMed/NCBI

Kapoor NS, Curcio LD, Blakemore CA, Bremner AK, McFarland RE, West JG and Banks KC: Multigene panel testing detects equal rates of pathogenic BRCA1/2 mutations and has a higher diagnostic yield compared to limited BRCA1/2 analysis alone in patients at risk for hereditary breast cancer. Ann Surg Oncol. 22:3282–3288. 2015. View Article : Google Scholar : PubMed/NCBI

Mattocks CJ, Morris MA, Matthijs G, Swinnen E, Corveleyn A, Dequeker E, Müller CR, Pratt V and Wallace A; EuroGentest Validation Group, : A standardized framework for the validation and verification of clinical molecular genetic tests. Eur J Hum Genet. 18:1276–1288. 2010. View Article : Google Scholar : PubMed/NCBI